Sandoz Group (OTCMKTS:SDZNY) Reaches New 52-Week High – Here’s What Happened

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price hit a new 52-week high on Wednesday . The company traded as high as $93.20 and last traded at $92.8650, with a volume of 5282 shares trading hands. The stock had previously closed at $85.01.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised shares of Sandoz Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Two analysts have rated the stock with a Strong Buy rating, According to MarketBeat, Sandoz Group presently has an average rating of “Strong Buy”.

Sandoz Group Stock Performance

The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.82 and a current ratio of 1.29. The firm’s fifty day simple moving average is $78.36 and its 200 day simple moving average is $69.00.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.